Review article · 2006 · Open access
Pharmacogenomics: Challenges and Opportunities
Annals of Internal Medicine, 145(10), 749–757 · Published 21 November 2006 · DOI 10.7326/0003-4819-145-10-200611210-00007
In brief
“Pharmacogenomics: Challenges and Opportunities” is a 2006 review article by Dan M. Roden and 13 co-authors, published in Annals of Internal Medicine. OpenAlex counts 323 citations as of 21 November 2026, which puts it in the top 3% of works published in 2006 by citations. It is open access: the full text is free to read at PubMed Central.
- Citations
- 323
- Most cited in
- 2025 (23)
- Field-weighted impact
- 3.32
- References
- 90
- Authors
- 14
Abstract
The outcome of drug therapy is often unpredictable, ranging from beneficial effects to lack of efficacy to serious adverse effects. Variations in single genes are 1 well-recognized cause of such unpredictability, defining the field of pharmacogenetics (see Glossary). Such variations may involve genes controlling drug metabolism, drug transport, disease susceptibility, or drug targets. The sequencing of the human genome and the cataloguing of variants across human genomes are the enabling resources for the nascent field of pharmacogenomics (see Glossary), which tests the idea that genomic variability underlies variability in drug responses. However, there are many challenges that must be overcome to apply rapidly accumulating genomic information to understand variable drug responses, including defining candidate genes and pathways; relating disease genes to drug response genes; precisely defining drug response phenotypes; and addressing analytic, ethical, and technological issues involved in generation and management of large drug response data sets. Overcoming these challenges holds the promise of improving new drug development and ultimately individualizing the selection of appropriate drugs and dosages for individual patients.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., Ring, H. Z., Shuldiner, A. R., Weinshilboum, R. M., & Weiss, S. T. (2006). Pharmacogenomics: Challenges and Opportunities. Annals of Internal Medicine, 145(10), 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007
MLA 9
Roden, Dan M., et al. “Pharmacogenomics: Challenges and Opportunities.” Annals of Internal Medicine, vol. 145, no. 10, 2006, pp. 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007.
Chicago
Roden, Dan M., Russ Biagio Altman, N L Benowitz, David Alastair Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, et al. 2006. “Pharmacogenomics: Challenges and Opportunities.” Annals of Internal Medicine 145 (10): 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007.
Harvard
Roden, D. M. et al. (2006) ‘Pharmacogenomics: Challenges and Opportunities’, Annals of Internal Medicine, 145(10), pp. 749–757. doi:10.7326/0003-4819-145-10-200611210-00007.
IEEE
D. M. Roden et al., “Pharmacogenomics: Challenges and Opportunities,” Annals of Internal Medicine, vol. 145, no. 10, pp. 749–757, 2006, doi: 10.7326/0003-4819-145-10-200611210-00007.
BibTeX
@article{roden2006pharmacogenomics,
title = {{Pharmacogenomics: Challenges and Opportunities}},
author = {Roden, Dan M. and Altman, Russ Biagio and Benowitz, N L and Flockhart, David Alastair and Giacomini, Kathleen M. and Johnson, Julie A. and Krauss, Ronald M. and McLeod, Howard L. and Ratain, Mark J. and Relling, Mary V. and Ring, Huijun Z. and Shuldiner, Alan R. and Weinshilboum, Richard M. and Weiss, Scott T.},
journal = {Annals of Internal Medicine},
year = {2006},
volume = {145},
number = {10},
pages = {749--757},
doi = {10.7326/0003-4819-145-10-200611210-00007},
url = {https://doi.org/10.7326/0003-4819-145-10-200611210-00007}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 14 | |
| 2018 | 4 | |
| 2019 | 10 | |
| 2020 | 5 | |
| 2021 | 11 | |
| 2022 | 8 | |
| 2023 | 11 | |
| 2024 | 13 | |
| 2025 | 23 | |
| 2026 | 20 |
Its field-weighted citation impact is 3.32: it has been cited 3.32 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- pharmacogenetics
- genetic variation
- drug response variability
- drug metabolism genes
- drug transporters
- therapeutic target
- candidate genes
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., Ring, H. Z., Shuldiner, A. R., Weinshilboum, R. M., & Weiss, S. T. (2006). Pharmacogenomics: Challenges and Opportunities. Annals of Internal Medicine, 145(10), 749–757. https://doi.org/10.7326/0003-4819-145-10-200611210-00007
How many times has this paper been cited?
323 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
Dan M. Roden, Russ Biagio Altman, N L Benowitz, David Alastair Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, Howard L. McLeod, Mark J. Ratain, Mary V. Relling, Huijun Z. Ring, Alan R. Shuldiner and 2 more.
What is the DOI of this paper?
10.7326/0003-4819-145-10-200611210-00007, permanently at https://doi.org/10.7326/0003-4819-145-10-200611210-00007. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.